Department of Health
and Human Services (HHS)
and Human Services (HHS)
November 17, 2020
NOT-OD-22-026 - Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
NOT-OD-21-042 - Notice of Correction to NOT-OD-21-020 Application and Submission Information
NOT-OD-20-038 - Notice of Special Interest: Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional)
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Office of The Director, National Institutes of Health (OD)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Library of Medicine (NLM)
Fogarty International Center (FIC)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
Food and Drug Administration (FDA)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women's Health (ORWH)
Tribal Health Research Office (THRO)
The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award.
Background
Ethical considerations are intrinsic to the responsible conduct of biomedical research and the translation of scientific and technological advances into practice. Research into bioethical issues can provide an evidentiary basis to guide conduct, content, and/or application of the biomedical and behavioral sciences and their associated policies, which becomes of increasing importance as science and societal views continue to evolve. Ethical questions and challenges are interlinked with many of NIH’s general areas of scientific priority, such as responding to public health needs (e.g., the opioid crisis, desire for precision medicine interventions) and emerging scientific opportunities (e.g., new data sharing infrastructure, innovative technologies). The investment in and the integration of bioethics-related research and policy demonstrate NIH’s commitment to safeguarding the integrity of the research that it conducts and supports, which, in turn, facilitates public participation and trust in the research enterprise.
This administrative supplement funding opportunity announcement will provide an opportunity for NIH-supported grantees to 1) conduct research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) develop projects that support certain types of capacity building efforts in bioethics.
Specific Areas of Interest
The NIH seeks to fund research on ethical considerations related to biomedical research and projects that support capacity building in bioethics. Applications should propose 1) research on topics that can provide or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity.
Research on topics that can provide or support the development of an evidence base that may inform future policy directions
Policies of interest include current NIH-issued policies or potential future policy directions, other federal policies, laws, and regulations, as well as policies governing the practice of research, medicine, or public health. Issues of interest fall within the scope of research supported by the NIH but may be beyond the focus of any one Institute or Center. Overarching areas of interest may include but are not limited to:
Projects that support certain types of capacity building efforts
Capacity building efforts of particular interest may include the development of educational content (e.g., curricula, practicum experiences for trainees, publicly accessible web-based modules) and new or innovative resources, tools, and/or strategies addressing bioethical challenges. Other types of projects (e.g., IRB management, funding for employees to meet human subjects research competency requirements, training slots) will not be supported by this funding mechanism.
Additional specific areas of interest
In addition to overarching areas of interest, individual NIH Institutes, Centers, and Offices as well as the FDA have indicated the following specific areas of research interest:
FIC
The Fogarty International Center (FIC) is interested in research and sustainable capacity building activities on ethical issues relevant to low- and middle-income countries, in particular, studies conducted by investigators in these countries.
NCATS
The National Center for Advancing Translational Sciences (NCATS) is interested in research on ethical issues that cross disease domains and span the translational research spectrum. NCATS encourages collaboration between translational researchers and bioethics researchers on projects addressing ethical challenges in moving discoveries from laboratory, clinic, and community into interventions that improve health.
Note concerning the Award Project Period: Supplement project and budget periods are limited to the remaining active budget period that started in FY21 for the existing parent award. To be eligible, the parent award must be active (i.e. not be in an extension period), and the activities proposed in the supplement must be accomplished within the remaining active budget period that started in FY21 for the existing parent award. The earliest anticipated start date is July 1, 2021
NCCIH
The National Center for Complementary and Integrative Health (NCCIH) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://nccih.nih.gov/about/plans
NCI
The National Cancer Institute (NCI) is interested in bioethics issues relevant to cancer research and care, such as issues raised in cancer clinical trials, cohort studies, cancer prevention studies, cancer centers, prospective biobanking, or projects using existing samples/tissues. Bioethical issues of interest include but are not limited to issues raised by new therapies/technologies; issues raised by the use of ancestry markers vs. ethnicity/race in research and treatment; innovative methods for recruitment and retention of participants who are underserved, hard to reach, or otherwise underrepresented in research; participant, community, or patient engagement; return of research results; participant and patient perception and comprehension; effective communication (including patient-provider and to/within families); increasing access to care for populations with cancer disparities. Additional issues may be found here: https://epi.grants.cancer.gov/bioethics-cancer-research.html. NCI encourages investigators to contact the parent grant program officer to address any budgetary issues prior to submitting a supplement application.
NEI
The National Eye Institute (NEI) is interested in bioethics applications that address topics relevant to research on blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems of individuals who are visually impaired or blind.
For information, please see https://www.nei.nih.gov/grants-and-training/funding-opportunities/programs-and-research-priorities
NHGRI
The National Human Genome Research Institute (NHGRI) is interested in applications which investigate and address bioethical issues related to the use of genetics and genomics in research, clinical medicine and healthcare, and society. NHGRI supports studies into specific conditions or diseases only if the proposed work will produce knowledge that is generalizable or transferable to other genetic conditions. Examples could include, but are not limited to: research on the implications of new and emerging genomic technologies and novel uses of existing technologies across cultures and communities, the use of polygenic risk scores in diverse ancestral populations, synthetic biology and the application of artificial intelligence and/or machine learning to genomic data.
NHLBI
The National Heart, Lung, and Blood Institute (NHLBI) is interested in research on bioethics issues relevant to its Strategic Vision (https://www.nhlbi.nih.gov/about/strategic-vision), and its focus on heart, lung, blood, and sleep conditions. Specific examples include, but are not limited to:
Investigators are encouraged to contact NHLBI staff to discuss their ideas
NIA
The National Institute on Aging (NIA) is interested in applications that address topics relevant to its core mission. For more information, please see: https://www.nia.nih.gov/about/mission
NIAAA
The mission of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to generate and disseminate fundamental knowledge about the effects of alcohol on health and well-being, and apply that knowledge to improve diagnosis, prevention, and treatment of alcohol-related problems, including alcohol use disorder, across the lifespan. NIAAA is interested in bioethics applications that address topics relevant to its mission, research objectives, and cross-cutting research areas as outlined in its strategic plan at https://www.niaaa.nih.gov/strategic-plan. Investigators are strongly encouraged to contact NIAAA staff to discuss their ideas.
NIAID
NIAID is interested in supporting supplemental projects that focus on ethical issues relevant to domestic and international collaborative research on HIV/AIDS or its co-morbidities (TB, malaria, hepatitis, sexually transmitted infections), other infectious diseases including those transmitted by vectors, immune-mediated diseases including allergy/asthma, autoimmune disease, and cell, tissue, or organ transplantation; ethics of clinical trials and implementation science; other ethical issues relevant to NIAID's scientific mission. Applications may include conceptual work in bioethics, or empirical work gathering and analyzing data relevant to ethical issues in research, or a combination of the two. For empirical projects, data collection may include quantitative or qualitative methods, or both. Although not intended to be an exhaustive list, of particular interest are projects on:
NIAMS
The mission of The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS also conducts and supports basic research on the normal structure and function of bones, joints, muscles, and skin. Clinical research areas include rheumatology, orthopedics, dermatology, metabolic bone diseases, heritable disorders of bone and cartilage, inherited and inflammatory muscle diseases, and sports and rehabilitation medicine. NIAMS is interested in bioethics topics relevant to its core mission.
NIBIB
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is interested in bioethics research relevant to its mission to support the development of innovative technologies in bioimaging and bioengineering. Areas of particular interest to NIBIB include, but are not limited to, ethical issues related to: artificial intelligence and machine learning; digital health and wearable/implantable technologies; connected health/mHealth and Point-of-Care (POC) technologies; clinical decision support systems (for healthcare professionals, caregivers, and/or patients); data sharing, privacy, and security; synthetic biological systems; neuromodulation technologies; health disparities and inclusion in biomedical research. Investigators are strongly encouraged to contact NIBIB staff to discuss their ideas. For more information on areas of interest to the NIBIB, please visit: https://www.nibib.nih.gov/research-funding
NICHD
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is interested in bioethical issues relevant to research involving children, pregnant women, and people with disabilities. Research in the fields of developmental biology, reproductive health, pediatrics, population health, and medical rehabilitation, research that addresses health disparities and improves prevention efforts among the populations served by NICHD, as well as areas identified as high-priority research areas to the institute are of particular interest. See https://www.nichd.nih.gov/grants-contracts/research-areas/priorities for the current research priorities for the institute and in https://www.nichd.nih.gov/about/org/strategicplan regarding future themes for the Institute.
NIDA
The National Institute on Drug Abuse (NIDA) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan, including research involving pregnant women using substances. For more information, please see: https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan
NIDCD
The National Institute on Deafness and Other Communications Disorders (NIDCD) is interested in applications that address topics in the areas of hearing, balance, taste, smell, voice, speech, and language. For more information, please see: NIDCD Strategic Plan
NIDCR
The National Institute of Dental and Craniofacial Research (NIDCR) is interested in applications that propose bioethics research relevant to dental, oral, and craniofacial health. For more information, please see: https://www.nidcr.nih.gov/about-us/mission. In addition to the overarching priority areas of this notice as related to dental, oral, and craniofacial health, the NIDCR is also interested in:
NIDDK
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is interested in applications that address topics relevant to its core mission. For more information, please see: NIDDK Research Areas
NIEHS
The National Institute of Environmental Health Sciences (NIEHS) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see:https://www.niehs.nih.gov/about/strategicplan/index.cfm
NIGMS
The National Institute of General Medical Sciences (NIGMS) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://www.nigms.nih.gov/about/overview/
NIMH
The National Institute of Mental Health (NIMH) is interested in bioethics applications that address a range of issues for individuals and communities relevant to its core mission, and the subjects and disorders which it serves as a primary lead at the NIH. Such areas include, but are not limited to:
For further information about Institute priorities, please see:https://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml
NIMHD
The National Institute on Minority Health and Health Disparities (NIMHD) is interested in supporting research projects on the ethical, legal, and social implications of research participation and/or health care for racial/ethnic minority or other health disparity populations. Areas of interest to NIMHD include but are not limited to studies that seek to understand or address cultural preferences; values and norms to ensure ethical and equitable conduct of research and delivery of health care; ethical integration of social and biomedical sciences (e.g., social epigenomics and incorporation of social determinants into the health care system); and mitigating stigmatization, group harms, and unintended social implications of research.
NINDS
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in research on neuroethical questions relevant to its mission to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. In addition to the general areas of interest listed above, areas of interest specific to NINDS include but are not limited to the ethical implications of: aspects of neuroscience research with human participants, such as differing stakeholder views on trial design, return of research results to participants, patient consent-related issues, or therapeutic misconception (including for rare diseases); research with brain organoids or ex vivo human brain tissue; collecting and sharing human brain data, such as de-identification, privacy, and re-use practices; the development and use of neuromodulation and neuroimaging technologies, such as device maintenance, data security, and intended and unintended uses of these technologies; predictive/diagnostic research related to brain disorders; and advances in neural recording and/or neuromodulation specifically for use in children. Consistent with the description of capacity-building efforts above, NINDS also is interested in capacity-building efforts including the development of educational content and new or innovative resources, tools, and/or strategies addressing neuroethical challenges relevant to the NINDS mission. Additional information about the NINDS mission may be found here: http://www.ninds.nih.gov/about_ninds/mission.htm. Note that applications must consider neuroethical questions and be within the general scope of the parent award. Also, NINDS will not consider supplement applications that include basic research activities or research with vertebrate animals.
NINR
NINR is interested in studies examining the bioethical issues related to nursing research that consider (including but not limited to):
Because of the complex, multi-factorial nature of this issue, multi-disciplinary teams are highly encouraged.
NLM
The National Library of Medicine (NLM) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan (https://www.nlm.nih.gov/pubs/plan/lrp17/NLM_StrategicReport2017_2027.html). Such topics include research into methods for reducing bias in health data sets and the tools used for mining them, enhancing public health information resources to meet the needs of underrepresented groups, and novel approaches for enhancing and assessing the informatics/data science workforce, including policies to promote scientific workforce diversity and inclusion and promote a safe and inclusive research environment.
FDA
FDA is interested in evaluating and promoting understanding of the ethical considerations related to the use of real-world data (RWD) to produce real-world evidence (RWE). Specifically, FDA is interested in research on how current ethical and human subject protection frameworks can be applied to the use of RWD. Examples of areas of interest include, but are not limited to:
FDA welcomes applications with innovative approaches to evaluate, understand, and expand knowledge regarding the ethical considerations of using RWD in clinical research. For background information on FDA’s RWE program, please see the following link: https://www.fda.gov/media/120060/download.
Scope of Support
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
The Office of the Director intends to commit at least $2,000,000 in FY 2021 to fund approximately 10 awards. The FDA intends to commit up to $500,000 in FY 2021.
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
Scientific/Research Contact(s)
Shari Feirman, PhD
Office of the Director (OSP/OD)
Telephone: 301-435-6350
Email: shari.feirman@nih.gov
Barbara Sina, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-402-9467
Email: sinab@mail.nih.gov
Juanita Marner
FDA CDER Office of Medical Policy
Email: juanita.marner@fda.hhs.gov
Elaine Collier, M.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0794
Email: colliere@mail.nih.gov
Charlisse Caga-anan, J.D.
National Cancer Institute (NCI)
Telephone: 240-276-6738
Email: charlisse.caga-anan@nih.gov
Cheri Wiggs, Ph.D.
National Eye Institute (NEI)
Telephone: (301) 451-2020
Email: wiggsc@mail.nih.gov
Nicole Lockhart, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2493
Email: lockhani@mail.nih.gov
Kathleen N. Fenton, MD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-6523
Email:Kathleen.Fenton@nih.gov
Kristina McLinden, PhD
National Institute on Aging (NIA)
Telephone: 301-827-2563
Email: mclindenka@nih.gov
Pamela Wernett, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-827-5391
Email: wernettpj@mail.nih.gov
Joana Roe
National Institute of Allergies and Infectious Disease (NIAID)
Telephone: 240-627-3213
Email: Joana.Roe@nih.gov
Marisol Espinoza-Pintucci, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-827-6959
Email: marisol.espinoza-pintucci@nih.gov
Todd Merchak
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8592
Email: merchakt@mail.nih.gov
Wendy Weber, N.D., Ph.D., M.P.H.
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-402-1272
Email:weberwj@mail.nih.gov
Tammara Jenkins, MSN, RN, PCNS-BC
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6837
Email: tjenkins@mail.nih.gov
Ruben Baler, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-2733
Email: baler@nida.nih.gov
Trinh Ly, M.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-4085
Email: trinh.ly@nih.gov
Leslie Frieden, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-496-4263
Email: leslie.frieden@nih.gov
Aynur Unalp-Arida, MD, MSc, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8879
Email: aynur.unalp-arida@nih.gov
Lindsey Martin, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984.287.4036
Email:lindsey.martin@nih.gov
Veerasamy Ravichandran
National Institute Of General Medical Sciences (NIGMS)
E-mail: veerasamy.ravichandra@nih.gov
James Churchill, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3621
Email: churchillj@mail.nih.gov
Nancy Jones, Ph.D., M.A.
National Institute on Minority and Health Disparities (NIMHD)
Telephone: 301-594-8945
Email: jonesna@nimhd.nih.gov
Khara Ramos, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-594-2614
Email: khara.ramos@nih.gov
Lynn Adams, Ph.D.
National Institute of Nursing Research (NINR)
Telephone: 301-594-8911
Email: adamsls@mail.nih.gov
Hua-Chuan Sim, MD
National Library of Medicine (NLM)
301-594-4882
simh@mail.nih.gov
Jamie Marshell White
Office Of Research On Women's Health (ORWH)
Phone: 301-496-9200
E-mail: jamie.white@nih.gov
Toccara Chamberlain
National Institute of Environmental Health Sciences (NIEHS)
Phone: 984.287.4482
E-mail: toccara.chamberlain@nih.gov
Peer Review Contact(s)
Not Applicable
Financial/Grants Management Contact(s)
Bruce Butrum
Fogarty International Center (FIC)
Telephone: 301-496-2075
Email: butrumb@mail.nih.gov
Mark Lauda
FDA CDER Office of Medical Policy
Email: Mark.Lauda@fda.hhs.gov
Zulema Eldridge
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-443-3066
Email: zulema.eldridge@nih.gov
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@gab.nci.nih.gov
Karen Robinson Smith
National Eye Institute (NEI)
Telephone: (301) 451-2020
Email: kyr@nei.nih.gov
Deanna Ingersoll
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-7858
Email: Deanna.Ingersoll@nih.gov
Tawana McKeither
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-9238
Email:tawana.mckeither@nih.gov
Jeff Ball
National Institute on Aging (NIA)
Telephone: 301-403-7736
Email: ballj@nia.nih.gov
Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: jfox@mail.nih.gov
Ann Devine
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2988
Email: Ann.Devine@niaid.nih.gov
Leslie Littlejohn
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5055
Email: Leslie.Littlejohn@nih.gov
Monique Day, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4797
Email: Monique.day@nih.gov
Shelley Carow
National Center For Complementary & Integrative Health (NCCIH)
Phone: 301.594.3788
E-mail: carows@mail.nih.gov
Bryan Clark, MBA
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6975
Email: clarkb1@mail.nih.gov
Pamela G. Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: pfleming@nida.nih.gov
Christopher Myers
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-0713
Email: myersc@mail.nih.gov
Diana Rutberg, M.B.A.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4798
Email: rutbergd@mail.nih.gov
Thuthuy Nguyen
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
301-594-8825
thuthuynguyen@niddk.nih.gov
Grace Olascoaga
National Institute Of General Medical Sciences (NIGMS)
E-mail: olascoag@nigms.nih.gov
Theresa Jarosik
National Institute of Mental Health (NIMH)
Telephone: 301-443-3858
Email: Theresa.Jarosik@nih.gov
Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: pg38h@nih.gov
Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: ChiefGrantsManagementOfficer@ninds.nih.gov
Ronald Wertz
National Institute of Nursing Research (NINR)
Telephone: (301) 594-2807
Email: wertzr@mail.nih.gov
Samantha Tempchin
National Library of Medicine (NLM)
301-496-4221
tempchins@mail.nih.gov
Jenny L Greer
National Institute of Environmental Health Sciences (NIEHS)
Phone: 984.287.3332
E-mail: jenny.greer@nih.gov